Karine Clauwaert

Karine Clauwaert

Karine Clauwaert

Chief Executive Officer - Abscint

Karine Clauwaert is a Pharmacist since 1992 and since 2003 a business developer in heart and soul.
Karine obtained a PhD in pharmaceutical sciences at Ghent University in the laboratory of toxicology in 1998.
Between 1997 and 2003 Karine was postdoc Ghent University and worked also at Micromass Europe as a product specialist in the Benelux.
Between 2003 and 2015 she was business development manager at VIB where she was responsible for proactive marketing of VIB technologies and for negotiating, drafting and concluding agreements between VIB and industry.
From 2015 until 2019 Karine was director business development at Eurofins CDMO. At Eurofins she scouted for new users Eurofins its CDMO services. This job entailed also the provision of quotations, negotiation of contracts and following up the projects with the customers.
Since 2019 Karine is an independent consultant helping companies with their business development activities and CMC related activities.
In 2020, Karine established, together with colleagues ABSCINT. ABSCINT is a clinical stage molecular imaging company that develops in-vivo diagnostics based on single domain antibodies

Join us in person on 19 May

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners